Compare Chevron Corp (CVX) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chevron Corp vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Chevron Corp trades at $211.98 (market cap $414.98B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Chevron Corp is far larger — about 68.7× Iovance Biotherapeutics Inc. Common Stock's market cap, and Chevron Corp pays a 3.37% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Chevron Corp for 101 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| CVX | IOVA | |
|---|---|---|
Market Cap | $414.98B | $6.04B |
Volume | 7,575,112 | 14,805,993 |
Sector | Energy | Health |
52-Week High | $217.73 | $14.82 |
52-Week Low | $146.72 | $1.81 |
Typical Hold Time | 101 Days | 0 Days |
Enterprise Value | $443.52B | $5.97B |
Dividend Yield | 3.37% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVX trades at $211.605, up 3.13% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock is supported by robust cash flow from operations of $33.94B in 2025 and a dividend of $1.78 per share. However, revenue and net income have declined from 2022 peaks, with 2025 revenue at $184.43B and net income at $12.30B. Analyst consensus is bullish with a $208.31 price target, though geopolitical tensions and oil price volatility pose risks.
The outlook for CVX is cautiously optimistic, driven by high oil prices and strategic investments like the $13.8B Argentina project. Investment opportunities include a solid dividend yield and potential upside from production growth. Key risks are exposure to fluctuating oil prices, geopolitical instability affecting supply chains, and declining profit margins. Investors should weigh strong cash generation against cyclical industry pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chevron Corp
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
